跳至主要内容
临床试验/NCT05328895
NCT05328895已完成不适用

Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease: Randomized Trial Controlled

Beijing Tongren Hospital1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
92
试验地点
1
主要终点
Pure tone thresholds.

研究概览

简要总结

Objective: To evaluate the effect of Transcutaneous auricular vagus nerve stimulation for the patients Meniere disease. Methods: We enrolled 88 patients at Beijing TongRen Hospital. All treatments were self-administered by the patients at home after training at the hospital. Patients completed questionnaires at baseline and after 4 weeks, 8 weeks, 12 weeks. Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry, visual scale of ear stuffiness and SF-36 were performed to evaluate the therapeutic effects. A difference of P < 0.05 was considered statistically significant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 61 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age >=18 and Age <=
  • Clinical diagnosis of meniere disease.

排除标准

  • History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
  • History of Otorhinolaryngology surgery.
  • Pregnant or lactating women.

结局指标

主要结局

Pure tone thresholds.

时间窗: Change from Baseline level of Pure tone thresholds at 12-weeks post-therapy.

The pure tone thresholds was performed in a sound-attenuated, double-walled booth with circumaural headphones (Sennheiser HD 280 for frequencies from 250 to 8000 Hz and Sennheiser HD 200 for frequencies from 8000 to 14000 Hz; Sennheiser, Old Lyme, USA) on a certified and calibrated audiometric system (Interacoustics, Middelfart, Denmark). Thresholds were measured using a probe-detection paradigm with pure tones presented for 250 ms at frequencies of 250, 500, 1000, 2000, 4000, 8000 Hz for each ear. To determine the LDL, the volume was set to 75 dB at 1000 Hz and then continuously raised in 5 dB steps (every 5 s) until the subject gave the signal that this volume was uncomfortable. When the volume exceeded 110 dB the test was stopped to prevent any hearing damage. The severity of hearing impairment was calculated as mild (20-40 dB), moderate (41-70 dB), severe (71-95 dB) and profound (\>95 dB). Normal hearing was defined as pure-tone thresholds less than 20 dB.

Tinnitus Handicap Inventory (THI)

时间窗: Change from Baseline scores of THI at 12-weeks post-therapy.

The THI is a 25-items, self-reported questionnaire regarding tinnitus handicap in daily life. The questionnaire comprises a 12-item functional subscale, an 8-item emotional subscale, and a 5-item catastrophic subscale. The three answer options are "yes," "sometimes," and "no," with scores of 4, 2, and 0, respectively. The overall score is the sum of 25 items (Range: 0-100). Higher scores equate to greater severity of tinnitus symptoms. measure the subjective tinnitus symptoms.

Dizziness Handicap Inventory (DHI)

时间窗: Change from Baseline scores of DHI at 12-weeks post-therapy.

The DHI is 25-items self-reported questionnaire that used to evaluate the functional, emotional, and physical impact of dizziness on patients' daily life. Among the overall 25 items of questions, 9 items are emotional related, 9 items are functional related, and 7 items are physical related questions. The three answer options are "yes," "sometimes," and "no," with scores of 4, 2, and 0, respectively. The overall score is the sum of 25 items (Range: 0-100). Higher scores equate to greater severity of dizziness symptoms.

Visual analogue scale (VAS)

时间窗: Change from Baseline scores of VAS of aural fullness at 12-weeks post-therapy.

The VAS scale of aural fullness consists of a 100 mm straight line with defined endpoints ("no aural fullness" and "worst aural fullness imaginable") on which the patients were asked to mark their experienced aural fullness (results in mm) at the actual time ("VAS now"). The higher VAS score (Range: 0-100) is correlated with a severe aural fullness.

次要结局

  • Video head impulse test (vHIT)(Change from Baseline number of pathological saccades and values of vHIT at 12-weeks post-therapy.)
  • The caloric test(Change from Baseline number of abnormal Unilateral Weakness (UW) at 12-weeks post-therapy.)
  • The Short Form Health Survey (SF36)(Change from Baseline scores of SF-36 at 12-weeks post-therapy.)

研究者

发起方
Beijing Tongren Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Transcutaneous Auricular Vagus Nerve Stimulation for... | 临床试验